drugset / Trial / NCT00092469

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

NCT00092469 ↗

Phase 3 Completed 151 enrolled Merck Sharp & Dohme LLC
RandomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety, tolerability, and immune response of an investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis, tetanus, hepatitis B, poliomyelitis, and Haemophilus influenza type b.

Timeline

Start
2002-03
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject V441 Vaccine — —